MR biopsy versus MR guided ultrasound fusion biopsy in prostate cancer diagnosis

MR biopsy versus MR guided ultrasound fusion biopsy in prostate cancer diagnosis - MR biopsy versus MR guided US fusion biopsy in prostate cancer diagnosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38691

Enrollment

Registered

2013-11-14

Start date

2013-10-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer Prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - At least one negatieve systematic ultrasound guided biopsy - MR-visible tumor >10 mm diameter - PI-RADS 4-5

Exclusion criteria

Exclusion criteria: - MR-visible tumor

Design outcomes

Primary

Measure	Time frame
The main study parameter is the percent change in success rate of MRgUSBx to MRgMRBx.	—

Secondary

Measure	Time frame
Other parameters include changes in spatial accuracy, procedure times, and detection rates.	—

Countries

Netherlands

Outcome results